Impact BioMedical, Inc. (IBO) is a publicly traded Healthcare sector company. As of May 21, 2026, IBO trades at $0.52 with a market cap of $58.04M and a P/E ratio of -1.52. IBO moved +4.03% today. Year to date, IBO is +3.30%; over the trailing twelve months it is -3.03%. Its 52-week range spans $0.36 to $6.17. Rallies surfaces IBO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
IBO financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. IBO recently traded at $0.52. Market cap is $58.04M. P/E ratio is -1.52. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $0.52 |
| Market Cap | $58.04M |
| P/E Ratio | -1.52 |
| EPS | $-0.38 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.17 |
| 52-Week Low | $0.36 |
| Volume | 450 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-11.87M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0 | $-11.87M | $-0.38 |
| 2024 | $0 | $-24.77M | $-2.30 |
IBO analyst coverage data. Average price target: $0.00.